Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Chemotherapy Induced usea and Vomiting - Overview
Chemotherapy Induced usea and Vomiting - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Chemotherapy Induced usea and Vomiting - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Chemotherapy Induced usea and Vomiting - Companies Involved in Therapeutics Development
Acacia Pharma Ltd
AcuCort AB
Aphios Corp
Artelo Biosciences Inc
Athenex Inc
Axim Biotechnologies Inc
Bod Australia Ltd
Camurus AB
ChemioCare USA Inc
Ci Therapeutics
Daewoong Pharmaceutical Co Ltd
Emerald Bioscience Inc
Ethicann Pharmaceuticals Inc
Helsinn Group
Hoverink Biotechnologies Inc
Huons Co Ltd
IntelGenx Corp
LipoSeuticals Inc
Luxe Pharmaceuticals Inc
MannKind Corp
Maxise Life Sciences Ltd
Medlab Clinical Ltd
Nevakar Inc
Pivot Pharmaceuticals Inc
Seri Therapeutics Inc
SoluBest Ltd
Suda Pharmaceuticals Ltd
Chemotherapy Induced usea and Vomiting - Drug Profiles
(netupitant + palonosetron hydrochloride) - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
APD-403 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
aprepitant - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
aprepitant - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
aprepitant - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ART-27.13 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
canbidiol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Canbis CINV - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dexamethasone - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
drobinol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
drobinol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
drobinol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
drobinol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
drobinol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
fosaprepitant - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
fosnetupitant chloride hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
granisetron - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
granisetron - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
granisetron hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LPI-1504 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
LPI-1505 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
NB-1222 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
netupitant - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
olanzapine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ondansetron - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ondansetron - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ondansetron hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
palonosetron - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
palonosetron hydrochloride - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
PGSN-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
RDN-18018 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SER-232 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecule to Agonize CB1 and CB2 for Chemotherapy Induced usea and Vomiting - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Zindol - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Chemotherapy Induced usea and Vomiting - Dormant Projects
Chemotherapy Induced usea and Vomiting - Discontinued Products
Chemotherapy Induced usea and Vomiting - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Chemotherapy Induced Nausea and Vomiting, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products by Targets, H2 2019
Number of Products by Stage and Targets, H2 2019
Number of Products by Mechanism of Actions, H2 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Number of Products by Top 10 Routes of Administration, H2 2019
Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Number of Products by Stage and Top 10 Molecule Types, H2 2019


List of Tables


Number of Products under Development for Chemotherapy Induced Nausea and Vomiting, H2 2019
Number of Products under Development by Companies, H2 2019
Number of Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Products under Development by Companies, H2 2019
Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Number of Products by Stage and Target, H2 2019
Number of Products by Stage and Mechanism of Action, H2 2019
Number of Products by Stage and Route of Administration, H2 2019
Number of Products by Stage and Molecule Type, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Acacia Pharma Ltd, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by AcuCort AB, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Aphios Corp, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Artelo Biosciences Inc, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Athenex Inc, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Axim Biotechnologies Inc, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Bod Australia Ltd, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Camurus AB, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by ChemioCare USA Inc, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Ci Therapeutics, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Daewoong Pharmaceutical Co Ltd, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Emerald Bioscience Inc, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Ethicann Pharmaceuticals Inc, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Helsinn Group, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Hoverink Biotechnologies Inc, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Huons Co Ltd, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by IntelGenx Corp, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by LipoSeuticals Inc, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Luxena Pharmaceuticals Inc, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by MannKind Corp, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Maxinase Life Sciences Ltd, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Medlab Clinical Ltd, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Nevakar Inc, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Pivot Pharmaceuticals Inc, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Serina Therapeutics Inc, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by SoluBest Ltd, H2 2019
Chemotherapy Induced Nausea and Vomiting - Pipeline by Suda Pharmaceuticals Ltd, H2 2019
Chemotherapy Induced Nausea and Vomiting - Dormant Projects, H2 2019
Chemotherapy Induced Nausea and Vomiting - Dormant Projects, H2 2019 (Contd..1), H2 2019
Chemotherapy Induced Nausea and Vomiting - Discontinued Products, H2 2019